89 related articles for article (PubMed ID: 9667227)
1. Different effects of naloxone on the growth hormone response to melatonin and pyridostigmine in normal men.
Coiro V; Volpi R; Capretti L; Giuliani N; Caffarri G; Colla R; Marchesi C; Chiodera P
Metabolism; 1998 Jul; 47(7):814-6. PubMed ID: 9667227
[TBL] [Abstract][Full Text] [Related]
2. Effect of melatonin on hypoglycemia and metoclopramide-stimulated arginine vasopressin secretion in normal men.
Coiro V; Volpi R; Caffarri G; Capretti L; Marchesi C; Giacalone G; Chiodera P
Neuropeptides; 1997 Aug; 31(4):323-6. PubMed ID: 9308018
[TBL] [Abstract][Full Text] [Related]
3. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
[TBL] [Abstract][Full Text] [Related]
4. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
Giustina A; Bossoni S; Bodini C; Cimino A; Pizzocolo G; Schettino M; Wehrenberg WB
Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540
[TBL] [Abstract][Full Text] [Related]
5. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
6. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Barini A
J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
[TBL] [Abstract][Full Text] [Related]
7. Alcoholism abolishes the effects of melatonin on growth hormone secretion in humans.
Coiro V; Vescovi PP
Neuropeptides; 1998 Jun; 32(3):211-4. PubMed ID: 10189054
[TBL] [Abstract][Full Text] [Related]
8. The role of the cholinergic pathway in growth hormone feedback.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
[TBL] [Abstract][Full Text] [Related]
9. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
[TBL] [Abstract][Full Text] [Related]
10. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
[TBL] [Abstract][Full Text] [Related]
11. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
[TBL] [Abstract][Full Text] [Related]
12. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men.
Coiro V; Volpi R; Bertoni P; Finzi G; Marcato A; Caiazza A; Colla R; Giacalone G; Rossi G; Chiodera P
Gerontology; 1992; 38(4):217-22. PubMed ID: 1358762
[TBL] [Abstract][Full Text] [Related]
13. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
14. Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone.
Paiva ES; Deodhar A; Jones KD; Bennett R
Arthritis Rheum; 2002 May; 46(5):1344-50. PubMed ID: 12115242
[TBL] [Abstract][Full Text] [Related]
15. The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.
Esposti D; Lissoni P; Mauri R; Rovelli F; Orsenigo L; Pescia S; Vegetti G; Esposti G; Fraschini F
J Endocrinol Invest; 1988 Feb; 11(2):103-6. PubMed ID: 3361078
[TBL] [Abstract][Full Text] [Related]
16. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
18. Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man.
Casanueva FF; Burguera B; Muruais C; Dieguez C
J Clin Endocrinol Metab; 1990 Jan; 70(1):234-7. PubMed ID: 2104624
[TBL] [Abstract][Full Text] [Related]
19. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
20. Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night.
Ghigo E; Arvat E; Mazza E; Mondardini A; Cappa M; Müller EE; Cammani F
Acta Endocrinol (Copenh); 1990 Jan; 122(1):37-40. PubMed ID: 2106188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
